Healthgen Biotech will attend the World Advanced Therapies & Regenerative Medicine Congress 2019 in London, UK Date: 5/15/2019 - 5/17/2019 Venue: Business Design Centre Address: Business Design Centre Ltd,, 52 Upper St, London N1 0QH Booth No: #6     The World Advanced Therapies&Regenerative Medicine Congress is Europe’s most important advance... Posted by Site editor|2019-05-04 LearnMore
[Breaking News] Healthgen Biotech has successfully completed the clinical trial Phase I of OsrHSA in the US   Wuhan Healthgen Biotechnology Corp. (Healthgen Biotech) has completed the clinical trial phase I of plant-derived OsrHSA, Recombinant Human Serum Albumin  (project No. HY1001), produced by the world’s first plant technology platform----OryzHiExp: rice endospe... Posted by Site editor|2020-03-31 LearnMore
Recombinant Human Serum Albumin(OsrHSA) From Rice Was Approved By USA FDA For Clinical Study On August 10, 2019, Wuhan Healthgen Biotechnology Co., Ltd. received approval from the FDA of the United States for clinical trials on OsrHSA injection that was produced from rice expression platform. This is the first blood product from China which was approved for clinical tr... Posted by Site editor|2019-08-10 LearnMore
Recombinant Human Serum Albumin(OsrHSA) Derived From Oryza Sativa Has Been Approved By CFDA For The Clinical Trial In China   OsrHSA, a recombinant human serum albumin derived from transgenic rice seeds has gained the approval of the clinical trial from Chinese Food and Drug Administration (CFDA) at 28 April, 2017. It is a milestone event in the research and applications of plant bioreactor, which ... Posted by Site editor|2017-05-22 LearnMore
Healthgen Biotech's tenth anniversary celebration   In 18th Dec 2016, the innovative high-tech enterprise- Wuhan Healthgen Biotechnology Corp.(Healthgen Biotech, Securities Code: 833101) which is focusing on developing, manufacturing and marketing a serious of recombinant proteins and small peptide products in the rice g... Posted by Site editor|2016-12-24 LearnMore
Pre 1 2 3 4 5 6 Next

Wuhan Healthgen Biotechnology Corp.

Tel. +86 027 59301891 Ext 8015

Fax. +86 027 59403931

E-mail cjing@oryzogen.com

268 Shendun 5th Road, East Lake High-Tech Development Zone, Wuhan, China 430020

Copyright ® Wuhan Healthgen Biotechnology Corp. All rights reserved. Terms and Conditions of Use
鄂ICP备12013293号-3